文献速递头颈外科

头颈部鳞状细胞癌根治性放疗后早期(90天)死亡率:一项基于人群的分析

Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
PubMed 文献 · Head Neck · 2018-10-08

该回顾性人群分析纳入1998至2014年在BC癌症机构接受根治性放疗的5658例头颈部鳞状细胞癌连续患者,90天死亡率为3.6%(203/5658),81%死于头颈癌。多因素分析显示年龄增加、口腔亚部位及晚期T和N分期与早期死亡风险增加相关(p < .05)。

要点

  • 根治性放疗后90天死亡率为3.6%(203/5658)。
  • 81%的早期死亡归因于头颈癌。
  • 年龄增加、口腔亚部位、晚期T和N分期与早期死亡风险增加相关(p < .05)。

核心结论

  • 早期死亡风险为3.6%。
  • 高龄且T和N分期晚期的患者早期死亡风险最高。

研究设计与样本

  • 回顾性、基于人群的分析,纳入1998至2014年在BC癌症机构接受根治性放疗的连续头颈部鳞状细胞癌患者(n = 5658)。
  • 采用逻辑回归分析确定与早期死亡相关的因素。

主要发现

  • 诊断时中位年龄为63岁。
  • 开始放疗后90天死亡率为3.6%(n = 203/5658)。
  • 81%的患者死因归因于头颈癌。
  • 多因素分析显示年龄增加、口腔亚部位及晚期T和N分期与早期死亡风险增加相关(p < .05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A retrospective, population-based analysis of 90-day mortality in patients with squamous cell carcinoma of the head and neck treated with radiotherapy was performed to determine the early mortality rate and associated risk factors. METHODS: Data were abstracted for all consecutive patients with cancer of the head and neck treated from 1998 to 2014 at the BC Cancer Agency with curative intent radiotherapy (n = 5658). Logistic regression analysis was used to determine factors associated with early mortality. RESULTS: The median age at diagnosis was 63 years. The mortality rate at 90 days after starting radiotherapy (RT) was 3.6% (n = 203/5658). The cause of death was attributed to head and neck cancer for 81% of patients. Multivariate analysis demonstrated that increasing age, oral cavity subsite, and advanced T and N classification were associated with an increased risk of early mortality (p < .05). CONCLUSIONS: The risk of early mortality was 3.6%. Elderly patients with advanced T and N classification had the highest risk of early mortality.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Hamilton SN, Tran E, Berthelet E, et al. Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis. Head Neck. 2018. PMID: 30295975. doi:10.1002/hed.25352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。